TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹4,373 Cr | ₹3,704 Cr | ₹3,364 Cr | ₹2,824 Cr | ₹2,431 Cr |
What is the latest Operating Profit of TORRENT PHARMACEUTICALS ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹4,373 Cr |
| Mar2025 | ₹3,704 Cr |
| Mar2024 | ₹3,364 Cr |
| Mar2023 | ₹2,824 Cr |
| Mar2022 | ₹2,431 Cr |
How is Operating Profit of TORRENT PHARMACEUTICALS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,373 Cr | 18.05 | |
| Mar2025 | ₹3,704 Cr | 10.13 | |
| Mar2024 | ₹3,364 Cr | 19.11 | |
| Mar2023 | ₹2,824 Cr | 16.15 | |
| Mar2022 | ₹2,431 Cr | - | |
Compare Operating Profit of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹180,347.6 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
| MANKIND PHARMA | ₹104,913.0 Cr | 2.7% | 1.8% | 5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 3.4% |
0.7% |
32.6% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses